appo@xmu.edu.cn
HOME
BROWSE
By ADRs
By Drugs
TOOL
ADR Similarity Search
Structure Similarity Search
DOWNLOAD
HELP
Adverse Drug Reaction Classification System
For ADR
For Drug
Search
----------All----------
ADR Term
ADReCS ID
MedDRA Code
MeSH ID
Drug Name
Drug ID
ATC Code
DrugBank ID
KEGG ID
PubChem ID
CAS RN
Molecular Formula
QuickSearch
Fuzzy Search
Accurate Search
ADR Ontology
ADR Term
Weight increased
ADR ID
BADD_A04650
ADR Hierarchy
13
Investigations
13.15
Physical examination and organ system status topics
13.15.01
Physical examination procedures and organ system status
13.15.01.006
Weight increased
Description
Increase in BODY WEIGHT over existing weight. [MeSH]
MedDRA Code
10047899
MeSH ID
D015430
ADR Severity Grade (FAERS)
Not Available
ADR Severity Grade (CTCAE)
Synonym
Weight gain | Weight increase | Weight increased | Wt gain | Weight above normal | Ponderal increased | Weight Gain | Gain, Weight | Gains, Weight | Weight Gains
Drugs Leading to the ADR
Drug ID
Drug Name
ADR Frequency (FAERS)
ADR Severity Grade (FAERS)
BADD_D01440
Methysergide maleate
-
-
BADD_D01445
Metoprolol
-
-
BADD_D01447
Metoprolol tartrate
-
-
BADD_D01454
Mianserin
-
-
BADD_D01466
Milnacipran hydrochloride
-
-
BADD_D01473
Minoxidil
-
-
BADD_D01476
Mirtazapine
-
-
BADD_D01480
Mitoxantrone
-
-
BADD_D01481
Mitoxantrone hydrochloride
-
-
BADD_D01484
Modafinil
-
-
BADD_D01487
Molindone
-
-
BADD_D01502
Moxifloxacin hydrochloride
-
-
BADD_D01507
Mycophenolate mofetil
-
-
BADD_D01508
Mycophenolic acid
-
-
BADD_D01511
Nabumetone
-
-
BADD_D01512
Nadolol
-
-
BADD_D01513
Nafarelin
-
-
BADD_D01527
Naltrexone
-
-
BADD_D01528
Naltrexone hydrochloride
-
-
BADD_D01537
Natalizumab
-
-
BADD_D01546
Nefazodone
-
-
BADD_D01547
Nefazodone hydrochloride
-
-
BADD_D01558
Nexium
-
-
BADD_D01564
Nicotine
-
-
BADD_D01566
Nifedipine
-
-
BADD_D01567
Nilotinib
-
-
BADD_D01570
Nisoldipine
-
-
BADD_D01585
Norethindrone
-
-
BADD_D01586
Norethindrone acetate
-
-
BADD_D01588
Nortriptyline
-
-
The 10th Page
First
Pre
10
11
12
13
14
Next
Last
Total 16 Pages
ADReCS-Target
ADR Term
Drug Name
Target